Orchid Pharma Limited (NSE:ORCHPHARMA)
India
· Delayed Price · Currency is INR 498.95
-9.60 (-1.89%)
At close: Mar 9, 2026
Orchid Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 25,306 | 39,363 | 52,994 | 15,643 | 11,641 | 98,268 | Upgrade
|
| Market Cap Growth | -52.35% | -25.72% | 238.77% | 34.38% | -88.15% | - | Upgrade
|
| Enterprise Value | 26,637 | 38,574 | 53,964 | 18,909 | 14,449 | 102,406 | Upgrade
|
| Last Close Price | 498.95 | 776.10 | 1044.85 | 383.25 | 285.20 | 2407.55 | Upgrade
|
| PE Ratio | 132.35 | 39.50 | 57.50 | 33.77 | - | - | Upgrade
|
| PS Ratio | 3.12 | 4.27 | 6.47 | 2.35 | 2.08 | 21.83 | Upgrade
|
| PB Ratio | 1.99 | 3.11 | 4.53 | 2.27 | 1.80 | 15.05 | Upgrade
|
| P/TBV Ratio | 2.01 | 3.15 | 4.59 | 2.27 | 1.80 | 15.06 | Upgrade
|
| P/FCF Ratio | - | - | 86.62 | - | 14.91 | 427.59 | Upgrade
|
| P/OCF Ratio | - | 204.86 | 42.06 | 85.30 | 12.59 | 416.64 | Upgrade
|
| EV/Sales Ratio | 3.28 | 4.18 | 6.59 | 2.84 | 2.58 | 22.75 | Upgrade
|
| EV/EBITDA Ratio | 59.60 | 32.97 | 49.33 | 22.57 | 27.21 | 175.38 | Upgrade
|
| EV/EBIT Ratio | - | 46.50 | 69.52 | 65.22 | - | - | Upgrade
|
| EV/FCF Ratio | - | - | 88.21 | - | 18.51 | 445.59 | Upgrade
|
| Debt / Equity Ratio | 0.22 | 0.14 | 0.12 | 0.48 | 0.41 | 0.69 | Upgrade
|
| Debt / EBITDA Ratio | 6.52 | 1.49 | 1.23 | 3.96 | 5.05 | 7.75 | Upgrade
|
| Debt / FCF Ratio | - | - | 2.21 | - | 3.43 | 19.70 | Upgrade
|
| Net Debt / Equity Ratio | 0.10 | 0.12 | 0.11 | 0.44 | 0.41 | 0.65 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.11 | 1.31 | 1.20 | 3.64 | 4.97 | 7.21 | Upgrade
|
| Net Debt / FCF Ratio | - | -1.17 | 2.15 | -4.58 | 3.38 | 18.33 | Upgrade
|
| Asset Turnover | - | 0.57 | 0.59 | 0.57 | 0.48 | 0.33 | Upgrade
|
| Inventory Turnover | - | 1.92 | 2.04 | 2.00 | 2.01 | 1.64 | Upgrade
|
| Quick Ratio | - | 0.93 | 0.79 | 0.65 | 0.73 | 1.18 | Upgrade
|
| Current Ratio | - | 2.83 | 3.04 | 1.35 | 1.65 | 3.87 | Upgrade
|
| Return on Equity (ROE) | - | 8.18% | 9.92% | 7.95% | -9.29% | -13.43% | Upgrade
|
| Return on Assets (ROA) | - | 3.20% | 3.49% | 1.55% | -1.80% | -2.34% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 5.90% | 6.00% | 3.40% | -3.90% | -4.60% | Upgrade
|
| Earnings Yield | 0.75% | 2.53% | 1.74% | 2.96% | -0.17% | -1.19% | Upgrade
|
| FCF Yield | - | -3.33% | 1.15% | -4.26% | 6.71% | 0.23% | Upgrade
|
| Buyback Yield / Dilution | 0.30% | -4.87% | -18.49% | - | - | -9914.82% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.